研究表明：利用大剂量的诺和诺德公司的抗凝血药来治疗非血友病的患者，比如出血中风，外伤，手术，器官移植等，可能会提高心脏病发作的风险。

The drug, NovoSeven, is a genetically engineered version of factor VII, a key protein missing in some people with the bleeding disease hemophilia.

Some doctors prescribe the drug in "off-label" use to stop unwanted bleeding associated with stroke, trauma, surgery, transplantation and other medical conditions. Doctors may prescribe any approved drug for any reason they want to.